33-105 : Drug Use-Results Survey of OPDIVO

JRCT ID: jRCT2041240121

Registered date:08/11/2024

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Cancer of unknown primary
• Date of first enrollment: 07/07/2022
• Target sample size: 100
• Study type: Observational

Outcome(s)

Primary Outcome

[Safety]
a) Occurrence status of adverse drug reactions and infections
b) Adverse events

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients with cancer of unknown primary, who have recieved OPDIVO for the first time
• Exclude criteria: Patients who have received OPDIVO previously

Related Information

• Primary Sponsor: Kuro Toshihiko